Myomo, Inc.
MYONYSECIK 1369290HealthcareFiscal year ends Dec 31
Reports and events: 179 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0520:15 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-335149 |
| 2026-08-0520:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-335109 |
| 2026-06-2913:06 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-286969 |
| 2026-06-2620:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-285450 |
| 2026-05-1822:05 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001161697-26-000118 |
| 2026-05-1420:05 ET | DEF 14A | Proxy statementPeriod 2026-06-25 | 0001193125-26-223981 |
| 2026-05-1320:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-221624 |
| 2026-05-0720:17 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-211988 |
| 2026-05-0720:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-211928 |
| 2026-04-2920:05 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001193125-26-191496 |
| 2026-04-1620:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-159060 |
| 2026-03-0920:16 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-098531 |
| 2026-03-0920:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-098504 |
| 2025-12-2923:30 ET | SCHEDULE 13D | Ownership report, active investor | 0001161697-25-000476 |
| 2025-12-1621:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-320896 |
| 2025-11-1021:15 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-274278 |
| 2025-11-1021:10 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-274238 |
| 2025-08-1120:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-106562 |
| 2025-08-1120:15 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-106564 |
| 2025-06-1812:40 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-087709 |
| 2025-06-1320:45 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-086306 |
| 2025-05-0720:15 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-065682 |
| 2025-05-0720:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-065657 |
| 2025-04-2512:30 ET | DEF 14A | Proxy statementPeriod 2025-06-11 | 0000950170-25-058354 |
| 2025-04-1012:40 ET | 8-K | 4.01 Change of auditor; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-052686 |
| 2025-03-1020:28 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-036349 |
| 2025-03-1020:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-036280 |
| 2025-02-2022:41 ET | 8-K | 1.01 Entry into a material agreement; 2.04 Item not in the standard list; 9.01 Financial statements and exhibits | 0000950170-25-023403 |
| 2024-12-0521:30 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-271571 |
| 2024-11-0621:15 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-122331 |
| 2024-11-0621:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122298 |
| 2024-08-1320:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-24-096326 |
| 2024-08-0620:15 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-091839 |
| 2024-08-0620:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-091801 |
| 2024-07-1520:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-179060 |
| 2024-07-0812:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-081953 |
| 2024-06-0720:05 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-157320 |
| 2024-05-0820:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-055687 |
| 2024-05-0820:10 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-055660 |
| 2024-05-0612:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-053228 |
| 2024-04-2612:30 ET | DEF 14A | Proxy statementPeriod 2024-06-05 | 0001193125-24-115929 |
| 2024-03-2820:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-038054 |
| 2024-03-0802:38 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-028326 |
| 2024-03-0721:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-027949 |
| 2024-03-0113:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-023543 |
| 2024-02-2221:54 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-018877 |
| 2024-01-1721:20 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-009264 |
| 2023-12-1921:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-23-071510 |
| 2023-11-0722:29 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-060417 |
| 2023-11-0721:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-060269 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.